Valuation Orion Oyj OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 11:13:09 2026-04-02 EDT			5-day change	1st Jan Change
82.75 ^USD	+4.81%		-.--%	+1.78%

07-06	Shilpa Biologicals Private Limited and Orion Corporation Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe	CI
06-30	Tenax Therapeutics, Inc. and Orion Corporation Enter Supply Agreement For Manufacture and Supply of Orally Administered Levosimendan Product	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,119	7,179	5,509	6,005	8,944	9,800	-	-
Change	-	40.25%	-23.26%	8.99%	48.95%	9.57%	-	-
Enterprise Value (EV) ¹	5,010	7,060	5,603	6,126	9,088	9,700	9,489	9,234
Change	-	40.91%	-20.65%	9.35%	48.35%	6.73%	-2.18%	-2.69%
P/E	26.5x	20.6x	25.5x	18.2x	17.9x	17.8x	15.1x	13.5x
PBR	6.86x	7.91x	6.19x	5.98x	6.97x	6.16x	4.98x	4.11x
PEG	-	0.3x	-0.7x	0.3x	0.3x	1.83x	0.8x	1.2x
Capitalization / Revenue	4.92x	5.36x	4.63x	3.89x	4.73x	4.71x	4.16x	3.86x
EV / Revenue	4.81x	5.27x	4.71x	3.97x	4.81x	4.66x	4.03x	3.64x
EV / EBITDA	17.3x	14.5x	17.2x	12x	13.2x	12.9x	10.7x	9.48x
EV / EBIT	20.6x	16.1x	20.4x	14.7x	14.4x	14.1x	11.7x	10.2x
EV / FCF	38.5x	21.7x	105x	29.7x	41.5x	20.1x	18.9x	15.2x
FCF Yield	2.6%	4.6%	0.95%	3.37%	2.41%	4.98%	5.28%	6.6%
Dividend per Share ²	1.5	1.6	1.62	1.64	1.8	1.907	2.113	2.358
Rate of return	4.11%	3.12%	4.13%	3.83%	2.83%	2.74%	3.03%	3.39%
EPS ²	1.38	2.49	1.54	2.35	3.56	3.907	4.612	5.142
Distribution rate	109%	64.3%	105%	69.8%	50.6%	48.8%	45.8%	45.9%
Net sales ¹	1,041	1,341	1,190	1,542	1,890	2,081	2,354	2,538
EBITDA ¹	289.1	487.1	326.4	509.4	688.3	752	883.9	974.4
EBIT ¹	243.3	439.6	274.9	416.6	631.6	689	814.5	905.7
Net income ¹	193.8	349.5	216.8	329.9	500.3	549.5	649.2	724.1
Net Debt ¹	-108.3	-118.7	93.3	121.7	144.4	-100.4	-311.5	-566.6
Reference price ²	36.52	51.24	39.27	42.78	63.65	69.65	69.65	69.65
Nbr of stocks (in thousands)	140,563	140,202	140,351	140,501	140,693	140,866	-	-
Announcement Date	2/10/22	2/9/23	2/13/24	2/25/25	2/12/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30.1x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.78x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.81x	5.6x	30.89x	2.5%	161B
Average	16.07x	6.44x	16.43x	2.44%	397.1B
Weighted average by Cap.	23.83x	7.85x	18.15x	2%